Nanoemulsion Drug Delivery Platform

Nanoemulsions are advanced colloidal systems consisting of oil and water phases stabilized by surfactants, with droplet sizes typically ranging from 20 to 200 nanometers. Unlike conventional emulsions, nanoemulsions are transparent or translucent and exhibit improved kinetic stability. Their nanoscale dimensions provide unique interfacial properties that enhance solubilization, bioavailability, and delivery efficiency of therapeutic agents. With their versatility and tunable characteristics, nanoemulsions have become one of the most promising platforms for modern drug delivery.

Formulation Principles

The design of a nanoemulsion requires careful consideration of formulation components and preparation methods. Selection of oils, surfactants, and co-surfactants is critical for achieving optimal droplet size, stability, and drug loading capacity. High-energy methods such as ultrasonication and high-pressure homogenization rely on mechanical force to break down droplets into nanoscale dimensions, offering reproducibility and scalability for industrial production. In contrast, low-energy techniques, including spontaneous emulsification and phase inversion, harness thermodynamic properties and molecular interactions to form nano-sized droplets under milder conditions. Each method carries advantages in terms of scalability, energy efficiency, and drug compatibility. Importantly, excipients must be biocompatible, non-toxic, and compliant with pharmacopeial standards to ensure safety and regulatory acceptance in clinical applications.

Figure 1. Overview of high energy and low energy methods for preparing nanoemulsions ^[1].

Advantages in Drug Delivery

Nanoemulsions provide significant advantages over conventional formulations, particularly for drugs with low aqueous solubility. Their ability to incorporate hydrophobic drugs into the oil phase enhances dissolution and absorption, resulting in improved oral bioavailability. The large interfacial surface area of nano-sized droplets further accelerates drug release and uptake. In addition, nanoemulsions can be engineered to provide controlled or sustained release, reducing the frequency of dosing and improving patient compliance. They also protect sensitive bioactive molecules, such as peptides and nucleic acids, from enzymatic or oxidative degradation, extending their therapeutic lifespan. By modifying droplet composition or incorporating ligands, nanoemulsions can be tailored for targeted drug delivery, thereby minimizing off-target effects and systemic toxicity.

Applications Across Therapeutics

The versatility of nanoemulsions has led to their application across diverse therapeutic fields. In oncology, they have been utilized to deliver poorly soluble chemotherapeutic agents, increasing tumor-specific uptake while reducing systemic side effects. Nanoemulsions have also been investigated as vaccine adjuvants, where their nanoscale size and lipid content enhance antigen presentation and immune response. In dermatology and transdermal drug delivery, nanoemulsions improve penetration through the skin barrier, offering effective delivery of active compounds for both therapeutic and cosmetic applications. Ocular formulations benefit from the extended residence time provided by nanoemulsions, ensuring more consistent dosing and improved drug bioavailability to the eye. Beyond these areas, their ability to encapsulate diverse molecules—from small hydrophobic drugs to biologics—demonstrates their broad potential in both current and future pharmaceutical development.

What We Offer

At Alfa Chemistry we build customizable nanoemulsion drug-delivery platforms tailored to your molecule and target route, combining excipient screening, droplet engineering, stability optimization, and scale-aware process design. We have experience selecting pharmacopeial oils and surfactants, designing low-energy and high-energy processes, and generating the analytical datasets required for downstream development. If you are considering a nanoemulsion strategy for an active pharmaceutical ingredient, biologic adjuvant, or topical formulation, please contact us for a business consultation.

Reference

1. Gupta, A.; et al. Nanoemulsions: formation, properties and applications. Soft matter. 2016, 12(11): 2826-2841.